11 April 22

World Parkinson’s day 2022

In time for World Parkinson’s day 2022, we present our first data utilizing a newly created C. elegans model to help prioritise a subset of PD GWAS genes worthy of further functional investigation.

  • English

This is the first systematic large-scale screening of ~100 risk genes for PD identified in recent years.

We generated a new C. elegans PD model that exhibits a readout for developed alpha-Synuclein inclusions in dopaminergic neurons, and follows their degeneration during aging. We then used these animals for functional screen of evolutionarily conserved risk genes for PD identified from the most recent GWAS data.

We performed a reverse genetic screen of ~100 Parkinson's disease (PD) risk genes that revealed new modulators of alpha-Synuclein neurotoxicity, a pathological hallmark of PD in humans.

Genome wide association studies over the years have revealed tens of risk signals linked to the idiopathic PD cases, however large majority of the genes located around these signals have not yet been functionally validated.

We recently published a study and we found 28 novel modulators of alpha-Synuclein-induced neuronal pathogenesis in this model, which should be further investigated functionally as potential new therapeutic targets for synucleinopathies, aging-related neurodegenerative diseases that include Parkinson’s disease.

Preprint summary is available in the Frontiers journal at this link: https://www.frontiersin.org/articles/10.3389/fnagi.2022.806000/abstract

What’s next?

  1. Validating the role of these genes in vertebrate animal model systems and human cell models for PD.
  2. Deep investigation of the mechanisms modulating neuronal pathogenesis in C. elegans models.

In the image you can see the microscopic nematode C. elegans with visualized dopaminergic neurons undergoing neurodegeneration. This new animal model help us to investigate the pathogenetic role of risk genes for Parkinson's disease, and other neurodegenerative diseases associated with aging at the level of the whole living organism.

The project was funded by the European Union's Horizon 2020 research and innovation programme under grant agreement No 844497, and by the Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano, Italy.



Pathogenetic pathways in age-related neurodegenerations as novel therapeutic targets for Parkinson’s ...

Duration: September 2019 - May 2022Funding: Excellence Science (Horizon 2020 ...

Other News & Events

1 - 10
Eurac Research logo

Eurac Research is a private research center based in Bolzano (South Tyrol) with researchers from a wide variety of scientific fields who come from all over the globe. Together, through scientific knowledge and research, they share the goal of shaping the future.

What we do

Our research addresses the greatest challenges facing us in the future: people need health, energy, well-functioning political and social systems and an intact environment. These are complex questions, and we are seeking the answers in the interaction between many different disciplines. In so doing, our research work embraces three major themes: regions fit for living in, diversity as a life-enhancing feature, a healthy society.

Great Place To Work
ISO 9001 / 2015ISO 9001:2015
ISO 27001ISO 27001:2013
ORCID Member

Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 4.0 International license.

In order to give you a better service this site uses cookies. Additionally third party cookies are used. By continuing to browse the site you are agreeing to our use of cookies.

Privacy Policy